Page 62 - Read Online
P. 62

Sabe et al. Vessel Plus 2024;8:2                                           Vessel Plus
               DOI: 10.20517/2574-1209.2023.95



               Original Article                                                              Open Access



               Comparative effects of canagliflozin and sitagliptin

               in chronically ischemic myocardium


               Sharif A. Sabe, Dwight D. Harris, Mark Broadwin, Cynthia M. Xu, Mohamed Sabra, Debolina Banerjee, M.
               Ruhul Abid, Frank W. Sellke

               Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert
               Medical School of Brown University, Rhode Island Hospital, Providence, RI 02905, USA.
               Correspondence to: Dr. Frank W. Sellke, Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research
               Center, Rhode Island Hospital, Alpert Medical School of Brown University, 2 Dudley Street, MOC 360, Providence, RI 02905,
               USA. E-mail: fsellke@lifespan.org

               How to cite this article: Sabe SA, Harris DD, Broadwin M, Xu CM, Sabra M, Banerjee D, Abid MR, Sellke FW. Comparative
               effects of canagliflozin and sitagliptin in chronically ischemic myocardium. Vessel Plus 2024;8:2. https://dx.doi.org/10.20517/
               2574-1209.2023.95

               Received: 1 Aug 2023  First Decision: 1 Dec 2023  Revised: 27 Dec 2023  Accepted: 5 Jan 2024  Published: 12 Jan 2024
               Academic Editors: Giuseppe Andò, Manel SabatéCopy Editor: Fangling Lan  Production Editor: Fangling Lan


               Abstract
               Aim: Recent studies demonstrate that sodium-glucose cotransporter 2 inhibitors (SGLT2i) and dipeptidyl
               peptidase-4 inhibitors (DPP4i), two classes of antidiabetic drugs, are cardioprotective. However, the mechanisms
               of these benefits and their comparative efficacy remain unclear. We aimed to compare the effects of these
               antidiabetic agents on cardiac function, perfusion, and microvascular density using a swine model of chronic
               myocardial ischemia.

               Methods: Chronic myocardial ischemia was induced in Yorkshire swine by ameroid constrictor placement to the
               left circumflex artery. Two weeks later, pigs were administered vehicle (“CON”, 8 pigs), 300 mg SGLT2i
               canagliflozin, (“CANA”, 8 pigs), or 100 mg DPP4i sitagliptin (“SIT”, 5 pigs) daily. Five weeks later, pigs were
               euthanized. Cardiac function, perfusion, collateralization, and protein expression were determined by pressure-
               volume catheter, microsphere analysis, immunofluorescence, and immunoblotting, respectively.

               Results: Compared with SIT, CANA was associated with improved stroke volume and cardiac output, with a trend
               towards reduced left ventricular stiffness. Both CANA and SIT trended towards improved perfusion compared to
               CON, but there were no differences between the two treatment groups. SIT was associated with improved capillary
               density with a trend towards improved arteriolar density compared to CANA. Both CANA and SIT were associated
               with increased expression of vascular endothelial cadherin compared to CON, without differences in treatment





                           © The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                        www.oaepublish.com/vp
   57   58   59   60   61   62   63   64   65   66   67